Clinical Trial Update: A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This is an update on an ongoing Phase 1/2a first-in-human study of BMS-986517 in adults with advanced solid tumors; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BMS-986517

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Solid Tumours | Phase 1, Phase 2 | Status: RECRUITING